CRISPR Patent Fight Between UC Berkeley, Broad Flares Up as USPTO Initiates New Interference

Jun 25, 2019

|

This article has been updated to add a comment from ERS Genomics CEO Eric Rhodes.

NEW YORK – The United States Patent and Trademark Office yesterday initiated a new patent interference in the CRISPR patent battle between the Broad Institute and the University of California, Berkeley.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Menu

CRISPR Patent Fight Between UC Berkeley, Broad Flares Up as USPTO Initiates New Interference

To read the full story....

Breaking News

Molecular Changes Wrought by Spaceflight Explored in Newly Published Studies

Recurrent SARS-CoV-2 Virus Mutations Do Not Increase Transmissibility, Study Finds

Somalogic Closes $121M Series A Funding

Pediatric Brain Tumor Proteomics Highlight Possible Treatment Targets, Biomarkers

In Brief This Week: Fluidigm, Centogene, Ginkgo Bioworks, Applied DNA Sciences, More

FDA Issues EUAs for Gravity Diagnostics Coronavirus Test, Sample Self-Collection Kit from RapidRona

The Scan

High Numbers Reported for Russian Vaccine

Masterpiece Microbiome

Limited Trust

Nucleic Acids Research Papers on Aging Atlas, Human Metagenomes, Drug Repositioning

What's Popular?

Tempus Gets CE Mark for xT Tumor Sequencing Assay

In Brief This Week: Fluidigm, Centogene, Ginkgo Bioworks, Applied DNA Sciences, More

FDA Issues EUAs for Gravity Diagnostics Coronavirus Test, Sample Self-Collection Kit from RapidRona

BTIG Downgrades Fulgent Genetics from Buy to Neutral

Startup Angstrom Bio Plans Saliva-Based COVID-19 Nucleic Acid Test on Nanopore Sequencing Platform

Sponsorships